☰

Lisa A. Kuttner-Kondo, Ph.D. - Publications

Affiliations: 
2001 Case Western Reserve University School of Medicine, Cleveland, OH, United States 
Area:
Immunology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Kuttner-Kondo L, Hourcade DE, Anderson VE, Muqim N, Mitchell L, Soares DC, Barlow PN, Medof ME. Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. The Journal of Biological Chemistry. 282: 18552-62. PMID 17395591 DOI: 10.1074/Jbc.M611650200  0.686
2007 Kuttner-Kondo L, Hourcade DE, Anderson V, Muqim N, Mitchell L, Moulds J, Soares DC, Barlow PN, Medof ME. Structure-based mapping of DAF's active site residues that decay accelerate the C3 convertases Molecular Immunology. 44: 201. DOI: 10.1016/J.Molimm.2006.07.128  0.621
2007 Kuttner-Kondo L, Muqim N, Crabb JW, Hollyfield JG, Medof ME. Effects on factor H function of polymorphisms linked to age-related macular degeneration Molecular Immunology. 44: 201. DOI: 10.1016/J.Molimm.2006.07.127  0.535
2003 Kuttner-Kondo LA, Dybvig MP, Mitchell LM, Muqim N, Atkinson JP, Medof ME, Hourcade DE. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. The Journal of Biological Chemistry. 278: 52386-91. PMID 14561755 DOI: 10.1074/Jbc.M304620200  0.668
2002 Hourcade DE, Mitchell L, Kuttner-Kondo LA, Atkinson JP, Medof ME. Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. The Journal of Biological Chemistry. 277: 1107-12. PMID 11694537 DOI: 10.1074/Jbc.M109322200  0.648
2001 Kuttner-Kondo LA, Mitchell L, Hourcade DE, Medof ME. Characterization of the active sites in decay-accelerating factor. Journal of Immunology (Baltimore, Md. : 1950). 167: 2164-71. PMID 11490001 DOI: 10.4049/Jimmunol.167.4.2164  0.665
2000 Brodbeck WG, Kuttner-Kondo L, Mold C, Medof ME. Structure/function studies of human decay-accelerating factor. Immunology. 101: 104-11. PMID 11012760 DOI: 10.1046/J.1365-2567.2000.00086.X  0.67
2000 Kuttner-Kondo L, Subramanian VB, Atkinson JP, Yu J, Medof ME. Conservation in decay accelerating factor (DAF) structure among primates. Developmental and Comparative Immunology. 24: 815-27. PMID 10906393 DOI: 10.1016/S0145-305X(00)00026-4  0.628
2000 Mitchell L, Kuttner-Kondo L, Medof M, Hourcade D. Identification of a factor B site involved in the dissociation of the AP C3 convertase by decay accelerating factor Immunopharmacology. 49: 64. DOI: 10.1016/S0162-3109(00)80180-0  0.645
2000 Kuttner-Kondo L, Mitchell L, Hourcade D, Medof M. Characterization of the active site in Decay-Accelerating Factor (DAF) Immunopharmacology. 49: 64. DOI: 10.1016/S0162-3109(00)80179-4  0.633
1996 Kuttner-Kondo L, Medof ME, Brodbeck W, Shoham M. Molecular modeling and mechanism of action of human decay-accelerating factor. Protein Engineering. 9: 1143-9. PMID 9010927  0.679
Show low-probability matches.